statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PolyPid Ends Equity Sales Agreement, No Penalties Incurred

PolyPid (PYPD) has released an update. PolyPid Ltd. has officially notified Cantor Fitzgerald of its decision to end their Controlled Equity Offeri...

PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference

PETACH TIKVA,Israel, Feb. 28, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), ( PolyPid or the Company ), a late-stage biopharma company aiming to improve surgical outcomes, today...

PolyPid GAAP EPS of -$3.97 misses by $1.18

PolyPid GAAP EPS of -$3.97 misses by $1.18...

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

More Than 100 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Unblinded Interim Analysis to be Conducted Once...

PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript

PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript...

PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial

Approximately 40 Centers Currently Open Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up; Top-line Results Expected in Second Half of 2024...

PolyPid files to sell 6.74M ordinary shares for holders

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024

PETACH TIKVA,Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ( PolyPid or the Company ), a late-stage biopharma company aiming to improve surgical outcomes, today...

PolyPid (NASDAQ:PYPD) and Assure (NASDAQ:IONM) Head to Head Comparison

PolyPid (NASDAQ:PYPD  Get Free Report) and Assure (NASDAQ:IONM  Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...

Reviewing PolyPid (NASDAQ:PYPD) and Assure (NASDAQ:IONM)

Assure (NASDAQ:IONM  Get Free Report) and PolyPid (NASDAQ:PYPD  Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two...

PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months. The firm's product candidates are designed to address unmet medical needs by delivering active pharmaceutical ingredients, or APIs, locally at predetermined release rates and durations over extended periods ranging from days to several months. The company was founded by Noam Emanuel on February 28, 2008 and is headquartered in Petach Tikva, Israel.

Volume	390.00
52-Wk High	$12.00
52-Wk Low	$3.38

PYPD Polypid Ltd

About

Feed

News

Sentiment

Earnings

Fundamentals